Correlation Between Cue Biopharma and GeoVax Labs
Can any of the company-specific risk be diversified away by investing in both Cue Biopharma and GeoVax Labs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cue Biopharma and GeoVax Labs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cue Biopharma and GeoVax Labs, you can compare the effects of market volatilities on Cue Biopharma and GeoVax Labs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cue Biopharma with a short position of GeoVax Labs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cue Biopharma and GeoVax Labs.
Diversification Opportunities for Cue Biopharma and GeoVax Labs
-0.53 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Cue and GeoVax is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Cue Biopharma and GeoVax Labs in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GeoVax Labs and Cue Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cue Biopharma are associated (or correlated) with GeoVax Labs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GeoVax Labs has no effect on the direction of Cue Biopharma i.e., Cue Biopharma and GeoVax Labs go up and down completely randomly.
Pair Corralation between Cue Biopharma and GeoVax Labs
Considering the 90-day investment horizon Cue Biopharma is expected to under-perform the GeoVax Labs. But the stock apears to be less risky and, when comparing its historical volatility, Cue Biopharma is 2.01 times less risky than GeoVax Labs. The stock trades about -0.09 of its potential returns per unit of risk. The GeoVax Labs is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest 179.00 in GeoVax Labs on September 3, 2024 and sell it today you would earn a total of 85.00 from holding GeoVax Labs or generate 47.49% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cue Biopharma vs. GeoVax Labs
Performance |
| Timeline |
| Cue Biopharma |
| GeoVax Labs |
Cue Biopharma and GeoVax Labs Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cue Biopharma and GeoVax Labs
The main advantage of trading using opposite Cue Biopharma and GeoVax Labs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cue Biopharma position performs unexpectedly, GeoVax Labs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GeoVax Labs will offset losses from the drop in GeoVax Labs' long position.| Cue Biopharma vs. DiaMedica Therapeutics | Cue Biopharma vs. Lyra Therapeutics | Cue Biopharma vs. Centessa Pharmaceuticals PLC |
| GeoVax Labs vs. DiaMedica Therapeutics | GeoVax Labs vs. Lyra Therapeutics | GeoVax Labs vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |